FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain
In September 2025, the U.S. Food and Drug Administration issued new draft guidance aimed at accelerating the development of non-opioid pain treatment options for chronic conditions. For physicians and patients in Sacramento and beyond, this represents a welcome expansion of the treatment toolkit — providing more options for individualized care.
Expanding Options, Not Restricting Them
It’s important to understand what this guidance is and what it isn’t. This is not another effort to restrict opioid access or further burden chronic pain patients who have already suffered under years of overly restrictive policies. Rather, it’s an acknowledgment that physicians need more tools at their disposal to treat the complex, individualized nature of chronic pain.
For some patients, opioid medications remain the most effective option for managing their pain and maintaining quality of life. These patients deserve continued access to appropriate treatment without stigma or unnecessary barriers. For other patients, non-opioid alternatives may be preferable — whether due to individual medical considerations, personal preference, or as part of a multimodal treatment approach.
The key is that physicians should have the freedom to choose the right treatment for each patient. More options means better individualized care.
What the New Guidance Addresses
The FDA’s draft guidance, titled “Development of Non-Opioid Analgesics for Chronic Pain,” is designed to streamline the regulatory pathway for bringing new pain treatments to market. Key elements include:
Broader treatment categories: Rather than requiring separate approvals for each individual pain condition, the guidance allows for treatments to be developed for broader categories of chronic pain, potentially speeding availability of new options.
Streamlined clinical trials: The guidance outlines more efficient approaches to demonstrating both safety and effectiveness, reducing unnecessary delays in the approval process.
Expedited development pathways: The FDA is encouraging the use of programs that can accelerate approval for promising treatments.
A More Balanced Conversation
FDA Commissioner Marty Makary, M.D., M.P.H., stated: “Physicians need more alternatives to opioid medications for patients suffering from chronic pain.”
While we welcome expanded treatment options, it’s worth noting that the conversation around pain management has too often focused on restricting access rather than expanding it. Chronic pain patients have borne the brunt of policies that, while well-intentioned, have left many struggling to receive adequate care.
The development of new non-opioid medications should complement — not replace — existing treatment options. Opioids, when prescribed appropriately by trained physicians who know their patients, remain an essential part of comprehensive pain management. The goal should never be to eliminate any effective treatment from a physician’s toolkit, but to ensure that doctors have every available option to help their patients.
What This Means for Our Patients
At Advanced Pain Diagnostic & Solutions, we have always believed in individualized, comprehensive pain management. We utilize the full spectrum of available treatments — from interventional procedures to medication management — tailored to each patient’s unique needs and circumstances.
As new treatment options become available, we will continue to evaluate them based on the evidence and incorporate those that can benefit our patients. But we will also continue to advocate for our patients’ right to receive whatever treatment is most appropriate for their individual situation, including opioid therapy when indicated.
Chronic pain is complex, and effective treatment requires physicians who are empowered to use their clinical judgment. We remain committed to providing that level of care to patients throughout the Sacramento region.
Looking Ahead
This FDA guidance is a step toward giving physicians more tools to treat chronic pain. We hope it signals a broader shift toward trusting doctors and patients to make treatment decisions together, rather than imposing blanket restrictions that ignore the realities of individualized care.
If you are living with chronic pain and seeking a practice that takes a comprehensive, patient-centered approach to treatment, we invite you to schedule a consultation with our team.